• AstraZeneca and Oracle launched a global AI collaboration to improve clinical trial recruitment and bring evidence-driven insights into patient care.
• Projects will span the US, Middle East and Europe, combining scientific expertise with Oracle's real-world data, cloud infrastructure and AI capabilities.
• The first program, with M42 in Abu Dhabi, will target hypertension care and clinical trial recruitment.
• The companies signed a non-binding term sheet for the collaboration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AstraZeneca plc published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.